Live Status Check

NCT07819136 Recruiting Status

Real-time enrollment status for this solid tumors clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: November 16, 2026 at 5:22 AM UTC

NCT07819136 Status Summary

NCT NumberNCT07819136
Recruiting StatusRecruiting
ConditionSolid Tumors
PhasePHASE1
Target Enrollment90 participants
Active Locations3 sites in the US
SponsorRecursion Pharmaceuticals Inc.
Last Updated on CT.govSeptember 29, 2026 (Sep 29, 2026)

About NCT07819136 Enrollment Status

As of November 16, 2026: Clinical trial NCT07819136 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Recursion Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT07819136

Is NCT07819136 still recruiting?

Yes, NCT07819136 is actively recruiting participants as of November 16, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT07819136 recruiting?

This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT07819136?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT07819136 status last updated?

The official ClinicalTrials.gov record for NCT07819136 was last updated Sep 29, 2026 (September 29, 2026). HelloStudys verifies this status automatically.

Browse More Solid Tumors Trials

Ready to Apply?

Check your eligibility for this clinical trial